Alexander Abitbol

7PUBLICATIONS
21CO-AUTHORS
Proteins and peptidesMolecular targetsPacific Peoples sport and physical activityBehavioural epidemiologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 26, 2026
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.

|May 21, 2026
Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.

|Apr 29, 2026
Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age.

|Aug 04, 2025
Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials.

Ronnie Aronson, Alexander Abitbol, Harpreet S Bajaj

|Feb 27, 2025
What do the guidelines say about use of biosimilar insulin therapy? Simple practical considerations to guide clinicians in different patient subgroups-Sharing Canadian perspectives.

A Abitbol, L Chu

|Aug 08, 2024
Real-world impact of adding a glucagon-like peptide-1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium-glucose co-transporter-2 inhibitor: The Impact GLP-1 CKD study.

Lisa Chu, Ryan M Bradley, Pernille Auerbach

Pageof 2

Frequent Collaborators

1 joint publications

L Chu

1 joint publications

Ronnie Aronson

1 joint publications

Harpreet S Bajaj

1 joint publications

Alice Y Y Cheng